NCT00711386View on ClinicalTrials.gov

GSK706769 Repeat Dose Study

PHASE1CompletedINTERVENTIONAL

Enrollment

40

Participants

Timeline

Start Date

May 16, 2008

Primary Completion Date

September 12, 2008

Study Completion Date

September 12, 2008

Conditions

Infection, Human Immunodeficiency Virus

Interventions

DRUG

GSK706769

50mg, 100mg, 200mg, or 400mg

OTHER

Placebo

Placebo

Trial Locations (1)

53704

GSK Investigational Site, Madison

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY